Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Tetrabenazine price, strengths & recalls

Pharmacies pay $39.15 for 30 tablets of Tetrabenazine 25 mg tablet this week, and from $20.22 to $39.15 across its 2 priced strengths and forms. 8 manufacturers make it. Its official label last changed on September 21, 2026.

Generic
Pharmacies pay$39.15for 30 tablets of 25 mg tablet-2.4% in 4 weeks
Fair cash price
$55.52
Strengths
2
Makers
8
Updated
Nov 11

Tetrabenazine price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
12.5 mg tablet$0.6740$20.22 / 30 tablets-4.0%-13.2%
25 mg tablet$1.30$39.15 / 30 tablets-2.4%-2.0%

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for tetrabenazine? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedSeptember 21, 2026
Version7 of 6
EffectiveSep 18, 2026
Read the label

These highlights do not include all the information needed to use TETRABENAZINE tablets safely and effectively. See full prescribing information for TETRABENAZINE tablets. TETRABENAZINE tablets, for oral use Initial U.S. Approval: 2008

This drug has a boxed warning

WARNING: DEPRESSION AND SUICIDALITY

Tetrabenazine can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington's disease. Anyone considering the use of tetrabenazine must balance the risks of depression and suicidality with the clinical need for control of chorea. Close observation of patients for the emergence or worsening of depression, suicidality, or unusual changes in behavior should accompany therapy. Patients, their caregivers, and families should be informed of the risk of depression and suicidality and should be instructed to report behaviors of concern promptly to the treating physician. Particular caution should be exercised in treating patients with a history of depression or prior suicide attempts or ideation, which are increased in frequency in Huntington's disease. Tetrabenazine is contraindicated in patients who are actively suicidal, and in patients with untreated or inadequately treated depression [see Contraindications (4), Warnings and Precautions (5.1)].

WARNING: DEPRESSION AND SUICIDALITY

See full prescribing information for complete boxed warning.

Increases the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington's disease (5.1)

Balance risks of depression and suicidality with the clinical need for control of chorea when considering the use of tetrabenazine tablets (5.2)

Monitor patients for the emergence or worsening of depression, suicidality, or unusual changes in behavior (5.1)

Inform patients, caregivers and families of the risk of depression and suicidality and instruct to report behaviors of concern promptly to the treating physician (5.1)

Exercise caution when treating patients with a history of depression or prior suicide attempts or ideation (5.1)

Tetrabenazine tablets are contraindicated in patients who are actively suicidal, and in patients with untreated or inadequately treated depression (4, 5.1)

Recent major changes (as listed on the label)

Contraindications (4) 9/2017

Warnings and Precautions, Tardive Dyskinesia (5.12-removal) 9/2017

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
7 approved generic applications on the market

Tetrabenazine questions

How much does tetrabenazine cost without insurance?

Pharmacies pay about $39.15 for 30 tablets of tetrabenazine 25 mg tablet ($1.30 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $55.52. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is tetrabenazine in shortage?

No shortage is reported for tetrabenazine right now. We check the national shortage list every day.

Has tetrabenazine been recalled?

No recalls are on record for tetrabenazine.

When did the tetrabenazine label last change?

The official label was last updated on September 21, 2026 (version 7). See what changed.

Talk about tetrabenazine

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.